Skip to content
Screener

Artivion AORT Investing Cash Flow

Investing Cash Flow at other companies

Abbott logo
AbbottABT
-$673M-15.6%
Edwards Lifesciences logo
Edwards LifesciencesEW
-$92.8M-209%
LeMaitre Vascular logo
LeMaitre VascularLMAT
-$11.08M+32.2%
Medtronic logo
MedtronicMDT
-$917M-87.1%
ITG
Integer HoldingsITGR
-$37.9M+80.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$7.73M+126%

Other financials

Income statement

See full
Revenue$125.8M+11.3%
Gross profit$80.5M+10.1%
Operating income-$8.4M-200%
Net income-$13.5M-1,104%
EPS (diluted)-$0.28-1,033%

Balance sheet

See full
Cash & equivalents$77.3M+44.6%
Total debt$408.0M+54.7%
Total equity$445.6M+6.1%
Total assets$1.1B+27.9%

Cash flow

See full
Operating cash flow-$1.3M-108%
CapEx$10.7M+227%
Free cash flow-$12.0M

Valuation

See full
Market cap$1.28B-33.5%
Enterprise value$1.61B-24.6%
P/S2.7×-2.0×

Profitability

See full
Gross margin64.4%+0.4pp
Operating margin4.4%0.0pp
Net margin-0.7%-0.3pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity-0.7%-0.3pp
Debt / equity0.9×+0.3×
Current ratio3.5×-1.3×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Artivion’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 1:57 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054746
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Acquisition of Endospan, net of cash acquired(116,661)
Payments related to sale of non-financial assets(1,500)
Other(3,000)
Net cash flows used in investing activities(139,912)(6,925)
Net cash flows from financing activities:
Proceeds from issuance of long-term debt, net148,875
Repayment of debt(134)
Proceeds from exercise of stock options and issuance of common stock2,6254,459

Item 1. Financial Statements.

FAQ

What is Artivion's investing cash flow?
Artivion (AORT) reported investing cash flow of -$129.41M in Q2 2026.
How has Artivion's investing cash flow changed year-over-year?
Artivion's investing cash flow decreased by 3837.0% year-over-year, from -$3.29M to -$129.41M.
What is the long-term trend for Artivion's investing cash flow?
Over 3 years (2022 to 2025), Artivion's investing cash flow has grown at a 57.7% compound annual growth rate (CAGR), from -$10.72M to -$42.04M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Artivion's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude